Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Meningioma × neratinib × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 2 Recurrence 1 Ovarian Neoplasms 1 Neuroma, Acoustic 1 Neurofibromatosis 2 1 Neoplasm Metastasis 1 Meningioma 1 Lymphoma 1 Leukemia 1 Ependymoma 1 Disease 1 Central Nervous System Neoplasms 1

Interventions

Nivolumab 2 Ipilimumab 2 CTLA-4 Antigen 2 pembrolizumab 1 neratinib 1 lutetium Lu 177 dotatate 1 brigatinib 1 abemaciclib 1 Specimen Handling 1 Radiosurgery 1 Magnetic Resonance Spectroscopy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04374305 2026-01-12

INTUITT-NF2

Massachusetts General Hospital

Phase 2 Active not recruiting

Ependymoma, Meningioma, Neuroma, Acoustic, Neurofibromatosis 2

Data powered by HemOnc (CC BY 4.0) Colophon ⚡